A Choppy May But Better Trades Lie Ahead for Biotech Stocks…Updates (4)
Update-4 6/4 11 a EDT Finally small cap biotechs catch a rally: among my holdings: CRSP, EDIT, PACB, VCYT . ARKG and IBB up. But large caps look better today.FDA authorizes Regeneron subcutaneous dosage for COVID-10 antibody therapy. Update-3 6/3 after close: Biotechs Hobble Along in a...
Biotech Stocks Cruise Through The Volatility…Update-1 Risk On
Update-1 5/27...AstraZeneca (AZN) inched up to $56.89 leading the large caps today. Moderna (MRNA) rose 2.25% to $179 level close to its 52 week high of $189. VIR was a big loser down 5.59% to $43.20. Both the ARKG and the XBI are in a stable intermediate bottom signaling a better market for...
Large Cap Biopharma-Good Stocks to Own While You are Waiting for the Momentum Trade…rally day!
May 20 The IBB was up over 2% and most biotechs were up. Momentum is expected to improve through July. We added to our bottom fishing on ARKG today at $78 level. Large caps perked up as well: BMY up 2.2%, AZN up 1,95%, RHHBY up 1.68%,LLY up 1.54%, -------------- Large Cap Biopharmas-Good Stocks...
Diversification is Key for Healthcare Portfolios: Update-3.. Large Caps Up
Update-3 11:20a 5/17. Large Caps continue to Look Good; Defensive with dividends and a little growth. ~1% movers as of mid-day trading: AZN, BIIB,GILD, GSK, REGN. IBB lags. Update-2 1:15p EDT Biotech stocks remain sluggish as NASDAQ rally slumps to red. Large caps favored but no traction in...
Biopharma Stocks Stall After Earnings, Lag Over 52 Weeks..REGN
5/7/21 10:30a EDT Nice Move in Regeneron (REGN). I finally made a good option trade . I wanted to own REGN which looks undervalued (PE about 12, P/S 6.30) among large cap biopharma. Q1 Results were good but concerns remain on Sanofi R&D relationship.The key to the trade was to buy two...